EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Association Between Dietary Advanced Glycation End Products ( AGEs ) and Pancreatic Fat Accumulation: Evidence From a Case–Control Study

Mohammad Reza Shahparvari, Zahra Yari iD, Maedeh Chegini, Mohammad Bahrizadeh, Amir Sadeghi iD, Azita Hekmatdoost iD

Endocrinology, Diabetes & Metabolism · 2026-07 · 9 (4)

DOI: 10.1002/edm2.70253 ↗

At a glance

Journal article in Endocrinology, Diabetes & Metabolism, published online on 2026-06-03. Written by Mohammad Reza Shahparvari and 5 co-authors. Institution: Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research In…. Major MEDLINE topics: Dietary Advanced Glycation End Products, Pancreatic Diseases, Glycation End Products, Advanced, Pancreas. 27 references. The full text is freely available (open access, CC BY 4.0). Funded by: Shahid Beheshti University of Medical Sciences.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Pancreatic steatosis (PS) is a metabolic condition associated with obesity, insulin resistance, and fatty liver disease. Advanced Glycation End Products (AGEs), abundant in processed and high‐temperature–cooked foods, have been linked to several metabolic disorders; however, their relationship with PS has not been previously examined.

Methods

In this case–control study, 278 individuals with gallstones, aged 55.7 ± 15.1 years, were classified as cases (with PS, n = 89) or controls (without PS, n = 189). PS was defined based on increased echogenicity of the pancreatic parenchyma relative to surrounding structures. Dietary intake was assessed using a food frequency questionnaire. Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for PS across quartiles of dietary AGE intake. The fully adjusted model included age, sex, total energy intake, body mass index, smoking status, and alcohol consumption.

Results

Higher dietary AGE intake was significantly associated with an increased likelihood of PS. In the crude model, odds of PS did not differ significantly across quartiles of dietary AGE intake compared with the lowest quartile. After adjustment for age and sex, individuals in the highest quartile had higher odds of PS (OR = 3.56; CI: 1.1–11.6; p = 0.040). In the fully adjusted model, significant associations were observed for the third (OR = 2.76; CI: 1.69–11.1) and fourth (OR = 3.3; CI: 1.79–13.7) quartiles of dietary AGE intake compared with the lowest quartile. A significant positive trend in the odds of PS was observed across increasing quartiles of dietary AGE intake (p for trend = 0.024).

Conclusion

Our findings suggest a potential role of dietary AGEs in pancreatic fat accumulation; however, causality cannot be inferred. Larger prospective and interventional studies are needed to confirm these associations and to determine whether reducing dietary AGE exposure can beneficially influence pancreatic fat.

Subjects

MeSH terms (MEDLINE)

Dietary Advanced Glycation End ProductsPancreatic DiseasesGlycation End Products, AdvancedPancreasHumansMiddle AgedCase-Control StudiesFemaleMaleAgedAdultGallstonesDiet

Author keywords

advanced glycation end productscase–control studydietmetabolic healthpancreatic steatosis

Substances

Dietary Advanced Glycation End ProductsGlycation End Products, Advanced

Authors and institutions

  • Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Nutrition Research, National Nutrition and Food Technology Research Institute and Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Research Institute for Gastroenterology and Liver Diseases of Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID profiles: Zahra Yari, Amir Sadeghi, Azita Hekmatdoost

Funding

  • Shahid Beheshti University of Medical Sciences

Cite

APA

Shahparvari, M. R., Yari, Z., Chegini, M., Bahrizadeh, M., Sadeghi, A., & Hekmatdoost, A. (2026). Association Between Dietary Advanced Glycation End Products ( AGEs ) and Pancreatic Fat Accumulation: Evidence From a Case–Control Study. Endocrinology, Diabetes & Metabolism, 9(4). https://doi.org/10.1002/edm2.70253

Vancouver

Shahparvari MR, Yari Z, Chegini M, Bahrizadeh M, Sadeghi A, Hekmatdoost A. Association Between Dietary Advanced Glycation End Products ( AGEs ) and Pancreatic Fat Accumulation: Evidence From a Case–Control Study. Endocrinology, Diabetes & Metabolism. 2026;9(4). doi:10.1002/edm2.70253

BibTeX
@article{Shahparvari2026,
  author = {Shahparvari, Mohammad Reza and Yari, Zahra and Chegini, Maedeh and Bahrizadeh, Mohammad and Sadeghi, Amir and Hekmatdoost, Azita},
  title = {Association Between Dietary Advanced Glycation End Products ( AGEs ) and Pancreatic Fat Accumulation: Evidence From a Case–Control Study},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2026},
  volume = {9},
  number = {4},
  doi = {10.1002/edm2.70253}
}
Start for free →